Leukemia
📧 Sign up to get email alerts when something new happens for Leukemia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2018-08-07Clinical Trial Update: Busulfan Plus Clofarabine Followed by Allogeneic Hematopoietic Stem Cell Transplantation [Phase 2]
Phase 2 trial evaluating busulfan plus clofarabine followed by allogeneic hematopoietic stem cell transplantation for leukemia and lymphoma.
-
CLINICAL_TRIALS trial_result · 2018-07-30Clinical Trial Update: Open Dose Escalating Trial to Determine the Maximum Tolerated Dose in Paediatric Patients With Advanced Cancers for Whom no Therapy is Known [Phase 1]
A Phase 1 open-dose escalation trial in pediatric patients with advanced cancers lacking standard therapy has completed, with results posted…
-
CLINICAL_TRIALS research · 2018-07-30Clinical Trial Update: A Study for Tyrosine Kinase Inhibitors Discontinuation
This clinical trial update discusses a study examining discontinuation of tyrosine kinase inhibitors for patients with leukemia.
-
CLINICAL_TRIALS withdrawal · 2018-07-26Clinical Trial Update: Patient-Driven Transfusion Thresholds in Hematological Disorders: A Pilot Study [NA]
A pilot clinical trial on patient-driven transfusion thresholds in hematological disorders sponsored by Emory University has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2018-07-13Clinical Trial Update: Evaluation of ClearLLab Leukemia and Lymphoma Panels
Completed clinical trial evaluating Beckman Coulter's ClearLLab leukemia and lymphoma panels for diagnostic use in leukemia and lymphoma con…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2018-07-12Clinical Trial Update: A Study on the Uterus, Ovarian and Reproductive Functions According to Conditioning Regimen and Pubertal Status at the Time of Stem Cell Transplantation in a Leukemia Pediatric Population [NA]
This clinical trial investigates how conditioning regimens and pubertal status at the time of stem cell transplantation affect uterine, ovar…
-
CLINICAL_TRIALS trial_result · 2018-07-10Clinical Trial Update: Hematopoietic Stem Cell Transplantation for the Treatment of Patients With Fanconi Anemia Lacking a Genotypically Identical Donor, Using a Chemotherapy Only Cytoreduction With Busulfan, Cyclophosphamide and Fludarabine [Phase 2]
Phase 2 trial evaluating hematopoietic stem cell transplantation after a chemotherapy-only cytoreduction with busulfan, cyclophosphamide, an…
-
CLINICAL_TRIALS trial_result · 2018-07-03Clinical Trial Update: Reduced-intensity, Related-donor Bone Marrow Transplantation Followed by High-dose Cyclophosphamide for Hematologic Cancers [Phase 2]
Phase 2 trial evaluating reduced-intensity, related-donor bone marrow transplantation followed by high-dose cyclophosphamide for hematologic…
-
CLINICAL_TRIALS trial_result · 2018-07-03Clinical Trial Update: Evaluation of Loratadine for G-CSF Induced Bone Pain in Patients With Hematologic Malignancies
The document reports the completion and update of a clinical trial evaluating loratadine for G-CSF–induced bone pain in patients with leukem…
-
CLINICAL_TRIALS trial_result · 2018-06-25Clinical Trial Update: Phase I Dose Escalation of BAY1143572 in Subjects With Acute Leukemia [Phase 1]
Phase I dose-escalation trial of BAY1143572 in subjects with acute leukemia has completed.
-
CLINICAL_TRIALS research · 2018-06-14Clinical Trial Update: WB-EMS and Nutrition in Patients With Hematological Malignancies [NA]
A trial update describing the evaluation of whole-body electromyostimulation (WB-EMS) with nutrition in patients with hematologic malignanci…
-
CLINICAL_TRIALS trial_result · 2018-06-07Clinical Trial Update: Interferon α for the Therapy of Minimal Residual Disease [NA]
Clinical trial update investigating interferon alpha for treating minimal residual disease in leukemia.
-
CLINICAL_TRIALS trial_result · 2018-05-31Clinical Trial Update: Clofarabine Plus Low-Dose Cytarabine for Patients With Higher-Risk Myelodysplastic Syndrome (MDS) [Phase 2]
Phase 2 clinical trial evaluating clofarabine plus low-dose cytarabine in higher-risk myelodysplastic syndromes has completed and results we…
-
CLINICAL_TRIALS trial_result · 2018-05-31Clinical Trial Update: RAD001 Study in Treatment of Relapsed or Refractory Acute Lymphocytic Leukemia [Phase 1, Phase 2]
Clinical trial update for RAD001 in relapsed or refractory acute lymphocytic leukemia (ALL) completed with results posted in 2018.
-
CLINICAL_TRIALS trial_result · 2018-05-24Clinical Trial Update: Allogeneic Transplant in HIV Patients (BMT CTN 0903) [Phase 2]
Phase 2 clinical trial evaluating allogeneic transplant in HIV-positive patients with leukemia or lymphoma; completed with results posted in…
-
CLINICAL_TRIALS trial_result · 2018-05-11Clinical Trial Update: Feasibility of Activity Monitoring in Patients With Cancer: Physical Activity Monitoring in Cancer Patients (PAMCaP)
The PAMCaP trial update reports the completion of a feasibility study evaluating physical activity monitoring in cancer patients. The resear…
-
CLINICAL_TRIALS trial_result · 2018-05-01Clinical Trial Update: Safety and Efficacy Evaluation of IM19 CAR-T Cells [Phase 1, Phase 2]
This document provides an update on the safety and efficacy evaluation of IM19 CAR-T Cells in leukemia across Phase 1 and Phase 2 trials.
-
CLINICAL_TRIALS trial_result · 2018-04-30Clinical Trial Update: Tacrolimus, Bortezomib, & Thymoglobulin in Preventing Low Toxicity GVHD in Donor Blood Stem Cell Transplant Patients [Phase 2]
Phase 2 trial evaluating a three-drug regimen (Tacrolimus, Bortezomib, and Thymoglobulin) to prevent low-toxicity graft-versus-host disease …
-
CLINICAL_TRIALS trial_result · 2018-04-25Clinical Trial Update: Clofarabine and Non-Myeloablative Allogeneic Hematopoietic Transplantation [Phase 1, Phase 2]
A phase 1/2 trial of Clofarabine combined with non-myeloablative allogeneic hematopoietic transplantation was terminated, with results poste…
-
CLINICAL_TRIALS trial_result · 2018-04-25Clinical Trial Update: Immune Mobilization of Autologous Peripheral Blood Stem Cells Using Interleukin-2 and GM-CSF [Phase 1]
Phase 1 study evaluating mobilization of autologous peripheral blood stem cells using interleukin-2 and GM-CSF; the trial has completed.
-
CLINICAL_TRIALS trial_result · 2018-04-23Clinical Trial Update: Bortezomib for Low or Intermediate-1 Myelodysplastic Syndrome (MDS) With p65 Activation [Phase 2]
A Phase 2 clinical trial of bortezomib in patients with low or intermediate-1 myelodysplastic syndrome with p65 activation has completed, wi…
-
CLINICAL_TRIALS trial_result · 2018-04-23Clinical Trial Update: Pacritinib for Patients With Lower-Risk Myelodysplastic Syndromes (MDS) [Phase 2]
Phase 2 trial update for pacritinib in lower-risk myelodysplastic syndromes has been terminated with results posted.
-
CLINICAL_TRIALS trial_result · 2018-04-17Clinical Trial Update: Study of VELCADE® With Mitoxantrone and Etoposide for Leukemias [Phase 1, Phase 2]
This clinical trial update reports Phase 1/2 results for a combination of bortezomib (Velcade) with mitoxantrone and etoposide in relapsed o…
-
CLINICAL_TRIALS trial_result · 2018-04-17Clinical Trial Update: Biparental HLA Haplotype Disparate T-cell Depleted Transplants for Patients Lacking an HLACompatible Donor [NA]
Clinical trial update on biparental HLA haplotype disparate T-cell depleted transplants for patients without an HLA-compatible donor has bee…
-
CLINICAL_TRIALS trial_result · 2018-04-11Clinical Trial Update: Vorinostat in Children [Phase 1, Phase 2]
Completed Phase 1/2 clinical trial evaluating vorinostat in pediatric patients with relapsed solid tumors, lymphoma, or leukemia.